Cigalah Group

Name

Cigalah Group

Legal name

Cigalah Group

Website

https://cigalah.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Jeddah

HQ country

Saudi Arabia

HQ region

Middle East

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Distribution: Distribution of pharmaceutical products from international partners to wholesale, retail, hospitals, health centers, and institutions across Saudi Arabia and GCC markets.
2. Consumer Products Distribution: Importation, warehousing, manufacturing support, and distribution of consumer goods across 10 Distribution Hubs, serving 16,000+ outlets with own private label products in addition to international brands.
3. Food Manufacturing and Export: Manufacturing and export of snack foods, cereals, and oats through Zawaq Foods facility. Production for international principals/brands plus own brands, exporting to GCC, Middle Eastern and North African markets.
4. Technology Transfer and Licensing: $208.5 million deal with Astrogen for technology transfer of autism treatment AST-001 across 16 MENA countries, including supply payments and double-digit royalties on future sales.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Core offering

Cigalah Group is a Saudi Arabian sales, distribution and marketing conglomerate that distributes pharmaceutical, healthcare, consumer goods, and bio-medical products from international principals to wholesale, retail, hospital and institutional channels across the Kingdom and GCC. It operates 10 consumer products distribution hubs and 5 healthcare/pharmaceutical distribution hubs, supported by a fleet of cash vans, a medical sales force, and 36,100 sqm of GDP-compliant temperature-controlled warehousing.

Product overview

Cigalah Group is a diversified distribution and trading conglomerate operating primarily in Saudi Arabia with over 100 years of history. The company operates through six main sectors: Healthcare Sector (pharmaceutical and healthcare product distribution serving 8,000+ pharmacies), Consumer Products Sector (consumer goods distribution with 10 distribution hubs), Business Development Sector (strategic planning and market development), Bio-Medical Sector (biomedical equipment distribution), Al Saf Sector and Al-Qantarah Sector (specialized subsidiaries). Key subsidiaries include Zawaq Foods (ISO 2200/JAS-ANZ accredited snack and cereal manufacturing) and Al-Tawun Chemicals (chemical logistics). Supporting services include pharmacovigilance, quality assurance compliant with SFDA GDP and ISO 9001/2015, compliance programs, and training academy. The group has over 5,000 employees and maintains partnerships with major pharmaceutical and consumer goods companies including Julphar, Allergan, Boehringer Ingelheim, Janssen, and over 40 other international brands.

Differentiator

Problem solved

Functional benefit

Brands

• Zawaq Foods: Snack foods and cereals manufacturer established in 1994, producing potato chips, corn snacks, filled biscuits, and cereal products.
• SAF Sector
• Al-Qantarah Sector
• Cigalah Surgical Packs Factory
• Al-Tawun Chemicals
• Alpha Pharma

Named customers3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

27 partnerships are on record, tiered core, flagship and minor.

• AumetcoreStrategic or Co-development Partner · 13 May 2026Healthcare-focused backer and investor in Aumet's $12 million Series A funding round led by Emkan Capital. Aumet operates an AI-first procurement operating system for healthcare providers and pharmacies across Jordan, Egypt, and Saudi Arabia.
• AstrogenflagshipStrategic or Co-development Partner · 7 January 2026$208.5 million exclusive agreement with Cigalah Medpharm Trading LLC for technology transfer and commercialization of autism treatment candidate AST-001 across 16 MENA countries. Includes $131 million for supply, $77.5 million upon regulatory approval, plus double-digit royalties on future sales.
• Aug PharmacoreChannel Partner/ Reseller/ Distributor · 1 January 2017Strategic partnership between Aug Pharma and Cigalah Egypt (affiliate of Cigalah Saudi Arabia) to boost operations in Egypt and MENA countries including Saudi Arabia and Gulf region.
• Boehringer IngelheimcoreChannel Partner/ Reseller/ Distributor · 1 January 2016Long-established partnership with Boehringer Ingelheim for innovative therapies in cardiovascular, respiratory diseases and diabetes. Jeddah office opening in 2016 marked major milestone in partnership.
• JulpharcoreChannel Partner/ Reseller/ DistributorMajor pharmaceutical partnership including joint venture for Julphar Saudi Arabia manufacturing facility in King Abdullah Economic City (SAR 200 million investment). Cigalah serves as the local partner for distribution and manufacturing of generic pharmaceutical products.
• AllergancoreChannel Partner/ Reseller/ DistributorStrategic partnership for Allergan Saudi LLC establishment, a multi-specialty healthcare company focused on branded pharmaceuticals, devices, and biological products. Celebrated inauguration in March 2017.
• Janssen (Johnson & Johnson)coreChannel Partner/ Reseller/ DistributorHealthcare sector partnership for pharmaceutical product distribution across Saudi Arabia.
• Gilead SciencescoreChannel Partner/ Reseller/ DistributorHealthcare sector partnership for pharmaceutical product distribution.
• TakedacoreChannel Partner/ Reseller/ DistributorHealthcare sector partnership for pharmaceutical product distribution.
• AmgencoreChannel Partner/ Reseller/ DistributorHealthcare sector partnership for pharmaceutical product distribution.
• MSD (Merck & Co.)coreChannel Partner/ Reseller/ DistributorHealthcare sector partnership for pharmaceutical product distribution including vaccines.
• SanoficoreChannel Partner/ Reseller/ DistributorHealthcare sector partnership for pharmaceutical product distribution.
• Abbott LaboratoriescoreChannel Partner/ Reseller/ DistributorHealthcare sector partnership for pharmaceutical and diagnostic product distribution. Also partner in bio-medical sector.
• BayercoreChannel Partner/ Reseller/ DistributorHealthcare sector partnership for pharmaceutical product distribution.
• Mylan (Viatris)coreChannel Partner/ Reseller/ DistributorHealthcare sector partnership for generic pharmaceutical product distribution.
• RB (Reckitt Benckiser)coreChannel Partner/ Reseller/ DistributorConsumer products partnership for OTC/healthcare products including Gaviscon.
• BiopharmacoreChannel Partner/ Reseller/ DistributorDistribution partner for ImmunityBio ANKTIVA launch in Saudi Arabia for BCG-unresponsive non-muscle invasive bladder cancer and metastatic non-small cell lung cancer treatments.
• United Naghi GroupcoreOthersParent organization with over 100 years of history in pharmaceutical and consumer products. Includes sister companies: Naghi Motors, Hafil Transport, Arabian Trading Supplies, Arabian Food Supplies, Yousef Naghi Electronics, Gulf Medical. Daughter companies: SAF Sector, Aghrass Medical, Zawaq Foods, Cigalah Surgical Packs Factory, Al-Qantarah Sector, Alpha Pharma.
• Buruj Cooperative InsuranceminorOthersInvestment holding in Buruj Cooperative Insurance Company.
• Julphar Saudi ArabiacoreOthersJoint venture manufacturing facility producing 1 billion tablets, 300 million capsules, and 30 million bottles of syrups/suspensions annually. SAR 200 million investment in King Abdullah Economic City.
• Batterjee PharmacoreChannel Partner/ Reseller/ DistributorInvestment and distribution partnership for Batterjee Pharma products.
• Friesland Campina Saudi ArabiacoreChannel Partner/ Reseller/ DistributorDistribution partnership for dairy and nutritional products.
• NutriciacoreChannel Partner/ Reseller/ DistributorHealthcare sector partnership for medical nutrition products including baby milk formula.
• DanonecoreChannel Partner/ Reseller/ DistributorHealthcare sector partnership for medical nutrition products.
• CSL BehringcoreChannel Partner/ Reseller/ DistributorHealthcare sector partnership for specialty pharmaceutical products.
• BioMarincoreChannel Partner/ Reseller/ DistributorHealthcare sector partnership for specialty pharmaceutical products.
• ActelioncoreChannel Partner/ Reseller/ DistributorHealthcare sector partnership for specialty pharmaceutical products.

Scale indicators10 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Salehiya Trading Company: One of the largest pharmaceutical and healthcare distribution companies in Saudi Arabia, supplying hospitals, pharmacies and government institutions. Directly comparable to Cigalah's healthcare sector in customer base (8,000+ pharmacies), product portfolio and B2B distribution model across the Kingdom.
• AJA Pharmaceutical Industries: Saudi pharmaceutical manufacturer and distributor serving local and regional markets with branded and generic products. Operates a comparable model of pharma distribution plus light manufacturing and serves the same Saudi pharmacy and hospital customer base as Cigalah's healthcare sector.
• Al-Jazira Pharmaceuticals: Saudi-based pharmaceutical distribution company providing medicines and medical supplies to pharmacies, hospitals and healthcare institutions across the Kingdom. Closely comparable to Cigalah's core healthcare distribution activity in customer mix and product portfolio.
• Pharma International Company: Jordan-headquartered pharmaceutical manufacturer and distributor with significant operations across Saudi Arabia and the broader MENA region. Comparable to Cigalah in its dual manufacturing-plus-distribution model and Saudi-focused go-to-market.

Broad incumbents

• SPIMACO Addwaeih: Major Saudi pharmaceutical manufacturer and distributor with a broad portfolio of branded generics and consumer healthcare products. Larger and more vertically integrated than Cigalah, SPIMACO overlaps in pharma distribution to Saudi pharmacies and hospitals and competes for the same multinational manufacturing/distribution partnerships.
• Dallah Healthcare Holding: Major Saudi healthcare conglomerate operating hospitals, clinics and pharmaceutical/healthcare distribution. Larger and more diversified than Cigalah, but overlaps in healthcare distribution and serves the same institutional pharmacy and hospital customers.

Regional players

• Tabuk Pharmaceuticals: Leading Saudi pharmaceutical manufacturer with distribution across MENA. Comparable to Cigalah's healthcare distribution activities and JV manufacturing model (e.g., Julphar Saudi), though primarily a manufacturer with selective distribution; competes for the same principals and government contracts.
• Al Ittihad Drug Store: UAE-based pharmaceutical distribution company serving pharmacies and healthcare institutions primarily in the UAE market. Comparable distribution model and customer base to Cigalah's healthcare sector, but geographically focused on the Emirates rather than Saudi Arabia.

Others

• Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer and Cigalah's joint venture partner in the SAR 200M Julphar Saudi Arabia manufacturing facility. Strategic partner rather than direct competitor, but operates in the same regional pharma value chain and serves overlapping MENA customers.

Emerging players

• Aumet: AI-first healthcare procurement platform operating across Jordan, Egypt and Saudi Arabia, in which Cigalah invested as part of a $12M Series A. Adjacent rather than directly competing, but represents the emerging digital procurement layer that could complement or disrupt traditional pharma distribution.

Market position

Strengths6 records

Weaknesses5 records

Competitive moat6 records

Key risks1 record

Key highlights1 record

Customer concentration

• YouTubeyoutube.com/watch?v=q2rRRQcbI4o

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cigalah Group